Zydus Lifesciences Shares Gain 3% on Launching New Cancer Drug; USFDA Approval for 2 New Injections
Shares of Zydus Lifesciences were trading 3% higher on 14 March on launching the new cancer drug Olaparib. The company has announced the launch of...
Download Unicorn Signals App
Powered By EquityPandit
